loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 211626 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 GRAVITI PHARMS (2)

filter

01 CAPSULE, DELAYED RELEASE;ORAL (2)

filter

01 RX (2)

filter

01 FENOFIBRIC ACID (2)

filter

01 No (2)

URL Supplier Web Content
CAPSULE, DELAYED R...
EQ 45MG FENOFIBRIC...
2019-07-18
211626
FENOFIBRIC ACID
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, DELAYED R...
EQ 135MG FENOFIBRI...
2019-07-18
211626
FENOFIBRIC ACID
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 211626

Looking for FDA Orange Book APPLICATION 211626 2

19

Graviti Pharmaceuticals, based in India, is a pharmaceutical company.

One of their notable products is CHOLINE FENOFIBRATE, with a corresponding application number 211626.

Regulatory Information RX

With a dosage strength EQ 45MG FENOFIBRIC ACID

Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL

Reference Listed Drug No

Approved since 2019-07-18

Therapeutic Equivalence (TE) Code AB

18

Graviti Pharmaceuticals, based in India, is a pharmaceutical company.

One of their notable products is CHOLINE FENOFIBRATE, with a corresponding application number 211626.

Regulatory Information RX

With a dosage strength EQ 135MG FENOFIBRIC ACID

Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL

Reference Listed Drug No

Approved since 2019-07-18

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY